Stock & Company Details
Resmed Inc. $RMD
Price:
N/A
N/A
141M
$32B
52 Week High:
N/A
10 Day Average Volume:
N/A
21.73
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
RMD technical indicators
Latest Resmed Inc. (RMD) indicator readings as of 2026-10-09.
RMD's 14-day RSI is 60.4, in neutral territory. At $230.05 it is trading 2.2% above its 200-day moving average of $225.20, and above its 50-day average of $225.19. Price sits near the upper Bollinger Band ($217.71 to $230.12). ADX reads 11.7, indicating a range-bound market rather than a trend.
RMD backtested strategy results
How 4 rule-based strategies performed on Resmed Inc. (RMD) over recent history, last backtested 2026-09-08. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +39.0% | 53% | 15 | -42.6% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -35.9% | 23% | 30 | -56.9% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -17.2% | 30% | 27 | -26.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | -19.4% | 61% | 23 | -38.5% |
Overview
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Finance Bot
Ask your questions
Start by typing a question below.
